INNOSTIC(301584.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
INNOSTIC
301584.SZ
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. engages in the distribution and sale of medical devices in China. The company offers vascular intervention products, such as cardiovascular, neurovascular, and peripheral vascular interventional devices, as well as vascular stents, balloons, catheters, guidewires, coils, and vascular filters; surgical instrument, including staplers, patches, and ultrasonic scalpels; in vitro diagnostic reagents and supporting instruments; and medical equipment comprising ultrasound equipment, imaging equipment, surgical navigation equipment, systems and other products. It also provides technical solutions for medical institution laboratory, pathology departments, and laboratories; solutions for distribution platforms for in vitro diagnostic manufacturers; operational services for testing centers and third-party laboratories; and professional after-sales and digital services.
385.17 B
301584.SZMarket value -Rank by Market Cap -/-

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    INNOSTIC: The net profit for the third quarter was 92.7977 million yuan, a year-on-year increase of 49.14%

    INNOSTIC announced that its revenue for the third quarter was 5.032 billion yuan, a year-on-year increase of 6.48%; net profit was 92.7977 million yuan, a year-on-year increase of 49.14%. Revenue for the first three quarters was 14.861 billion yuan, a year-on-year increase of 10.18%; net profit was 230 million yuan, a year-on-year increase of 45.01%

    Zhitong·
    SZ
    301584
    -1.56%
    Zhitong·
    SZ
    301584
    -1.56%

    INNOSTIC: The company does not have brain-computer interface products or related technology reserves

    On October 27th, INNOSTIC stated on the interactive platform that the company currently has no sales of brain-computer interface products, nor does it have relevant technology research and reserves

    Zhitong·
    SZ
    301584
    -1.56%
    Zhitong·
    SZ
    301584
    -1.56%

    INNOSTIC: Currently not engaged in the business of testing reagents related to Chikungunya fever symptoms

    On October 13th, INNOSTIC stated on the interactive platform that the company currently does not have a business related to testing reagents for symptoms of Chikungunya fever

    Zhitong·
    SZ
    301584
    -1.56%
    Zhitong·
    SZ
    301584
    -1.56%

    On the first day of listing, the new stock of the Growth Enterprise Market, INNOSTIC, once rose over 500%, currently reported at 42.07 yuan/share

    Zhitong·
    SZ
    301584
    -1.56%
    Zhitong·
    SZ
    301584
    -1.56%

    Shanghai C&D Innostic Medical Technology Surges 410% in Shenzhen Debut

    (MT Newswires) -- Shanghai C&D Innostic Medical Technology (SHE:301584) opened at 36.00 yuan per share on its first day of trading on the Shenzhen Stock Exchange. This marked a 410% jump from the medical imaging company's initial public offering price of 7.05 yuan per share.

    marketscreener·
    SZ
    301584
    -1.56%
    marketscreener·
    SZ
    301584
    -1.56%
    © 2026 Longbridge｜Disclaimer